发明名称 | Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors | ||
摘要 | The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same. | ||
申请公布号 | US9249132(B2) | 申请公布日期 | 2016.02.02 |
申请号 | US201113991973 | 申请日期 | 2011.12.16 |
申请人 | Nivalis Therapeutics, Inc. | 发明人 | Sun Xicheng;Qiu Jian;Stout Adam |
分类号 | C07D417/10;C07D215/20;C07D217/16;C07D239/34;C07D241/42;C07D253/10;C07D401/04;C07D403/10;C07D405/04;C07D409/04;C07D413/10;C07C65/105;C07C65/24;C07D213/79;C07D239/28;C07D241/24;C07D295/155;C07D215/06;C07D239/74;C07D409/14;C07D215/60;C07D239/26;C07D401/10;C07D217/04 | 主分类号 | C07D417/10 |
代理机构 | Swanson & Bratschun, L.L.C. | 代理人 | Swanson & Bratschun, L.L.C. |
主权项 | 1. The compound of Formula 1: wherein R1 is selected from the group consisting of H, F, and Cl; R2a and R2b are independently selected from the group consisting of H, F, Cl, Br, Me, OCH3, and cyano; R2c is selected from the group consisting of H, F, Cl, Br, Me, and OCH3; X is selected from the group consisting of A is selected from the group consisting of R3 is selected from the group consisting of F, Cl, Br, CH3, CF3, OCH3,cyano, N(CH3)2, and morpholino; n is selected from the group consisting of 0, 1, and 2; R4 is selected from the group consisting of H, F, Cl, Br, CH3, CF3, OCH3, cyano, N(CH3)2, and morpholino; with the proviso that when X is and A is COOH, then at least one of R1, R2a, R2b, R2c, and R4 is not hydrogen, or n must be >0, and R3 when meta to naphthalene, cannot be CH3. | ||
地址 | Boulder CO US |